Evidence map›Paper›PMID 35205103›Full record

ReviewBiology2022

The Role of Connexin Hemichannels in Inflammatory Diseases.

Bo Peng, Chengping Xu, Shuaiwei Wang, Yijie Zhang, Wei Li

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06162065 (Effectiveness of Oral Boldo in Improving Urinary Symptoms and Body Stability in Women Diagnosed With Overactive Bladder), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06162065 phase1unknown statusnot on this mapstarted 2023, after this paper: background citation

Effectiveness of Oral Boldo in Improving Urinary Symptoms and Body Stability in Women Diagnosed With Overactive Bladder

TypeinterventionalSponsorUniversidad de ValparaisoRan2023 to 2024Enrolled10ConditionsUrinary Bladder, OveractiveArmsOxybutynin Pill, Boldo supplement
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Discovery ofBiology · 2023
    Article
  20. The Potential Role of Connexins in the Pathogenesis of Atherosclerosis.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bo PengSepsis Laboratory, Center for Translational Medicine, Henan University, Kaifeng 475000, China.
Chengping XuSepsis Laboratory, Center for Translational Medicine, Henan University, Kaifeng 475000, China.ORCID 0000-0002-6850-5262
Shuaiwei WangSepsis Laboratory, Center for Translational Medicine, Henan University, Kaifeng 475000, China.
Yijie ZhangSepsis Laboratory, Center for Translational Medicine, Henan University, Kaifeng 475000, China.
Wei LiSepsis Laboratory, Center for Translational Medicine, Henan University, Kaifeng 475000, China.ORCID 0000-0002-7941-7022
Henan University · CN

Funding

Natural Science Foundation of China 81671959Natural Science Foundation of China U1704171
6 · The paper itself

Abstract

The connexin protein family consists of approximately 20 members, and is well recognized as the structural unit of the gap junction channels that perforate the plasma membranes of coupled cells and, thereby, mediate intercellular communication. Gap junctions are assembled by two preexisting hemichannels on the membranes of apposing cells. Non-junctional connexin hemichannels (CxHC) provide a conduit between the cell interior and the extracellular milieu, and are believed to be in a protectively closed state under physiological conditions. The development and characterization of the peptide mimetics of the amino acid sequences of connexins have resulted in the development of a panel of blockers with a higher selectivity for CxHC, which have become important tools for defining the role of CxHC in various biological processes. It is increasingly clear that CxHC can be induced to open by pathogen-associated molecular patterns. The opening of CxHC facilitates the release of damage-associated molecular patterns, a class of endogenous molecules that are critical for the pathogenesis of inflammatory diseases. The blockade of CxHC leads to attenuated inflammation, reduced tissue injury and improved organ function in human and animal models of about thirty inflammatory diseases and disorders. These findings demonstrate that CxHC may contribute to the intensification of inflammation, and serve as a common target in the treatments of various inflammatory diseases. In this review, we provide an update on the progress in the understanding of CxHC, with a focus on the role of these channels in inflammatory diseases.

Indexed as

ATPchannel blockerconnexin hemichannelgap junctionsHMGB1inflammationinnate immune cellsischemiamimetic peptidesepsis

Identifiers

PMID35205103
PMCPMC8869213
OpenAlexW4210681046

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.